Investor Presentaiton slide image

Investor Presentaiton

SAGA¹: South Africa, Sub-Saharan Africa and Cipla Global Access SA Private Market 20% YoY ZAR Terms South Africa Private South Africa Tender Others (SSA & CGA) Q3 Y-o-Y $ Mn Q3 Q-o-Q $ Mn 30 30 33 33 33 28 29 21 29 31 16% 47 55 56 55 Q3 FY19 Q3 FY20 Q2 FY20 Q3 FY20 Cipla Key Business Highlights South Africa private market continued the momentum growing over 2 times the market at 6.5% as per IQVIA MAT Dec' 19 Cipla continues to rank as the 3rd largest pharmaceutical corporation within the South African private market, in both volume and value Sub-Saharan Africa business grew by 12% on a year on year basis and the CGA business also delivered a growth of 7% over last year Investor Presentation: Q3FY20 1. Financial numbers are rounded off 8
View entire presentation